Xiangyu Medical Co.,Ltd Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	778.76	722.46	743.18	663.78	726.31	829.62
Short-Term Investments	-	249.79	-	-	-	-
Trading Asset Securities	120.59	52	-	162.19	636.47	648.14
Cash & Short-Term Investments	899.35	1,024	743.18	825.98	1,363	1,478
Cash Growth	5.93%	37.82%	-10.02%	-39.39%	-7.78%	203.29%
Accounts Receivable	80.4	60.82	67.7	57.99	34.35	43.03
Other Receivables	19.58	9.93	15.24	7.42	5	4.37
Receivables	99.98	70.75	82.95	65.41	39.35	47.4
Inventory	358.07	304.2	238.21	241.37	222.82	159.4
Prepaid Expenses	-	-	-	-	-	1.78
Other Current Assets	89.04	87.11	77.38	61.6	43.42	30.18
Total Current Assets	1,446	1,486	1,142	1,194	1,668	1,717
Property, Plant & Equipment	1,440	1,397	1,216	834.36	407.96	170.9
Long-Term Investments	37.03	75.69	266.03	258.52	17.09	16.71
Other Intangible Assets	220.36	214.37	216.89	207.7	204.25	208.78
Long-Term Accounts Receivable	-	27.77	33.53	47.79	43.03	50.2
Long-Term Deferred Tax Assets	18.5	13.92	9.55	11.22	14.7	11.4
Long-Term Deferred Charges	20.34	26.18	16.57	5.72	1.51	1.47
Other Long-Term Assets	113.9	26.89	27.14	32.47	11.15	6.57
Total Assets	3,296	3,268	2,928	2,592	2,368	2,183

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Accounts Payable	109.59	122.65	135.81	109.69	103.87	27.71
Accrued Expenses	26.7	54.99	60.37	62.61	45.46	33.49
Short-Term Debt	420.12	482.52	354.1	27.02	17.15	-
Current Portion of Long-Term Debt	22.95	1.44	-	-	-	-
Current Portion of Leases	-	2.69	1.12	-	-	-
Current Income Taxes Payable	6.58	0.04	1.45	5.06	2.01	8.71
Current Unearned Revenue	200.99	181.48	127.97	107.56	135.69	64.23
Other Current Liabilities	114.69	105.03	53.89	60.21	47.62	47.27
Total Current Liabilities	901.62	950.84	734.71	372.14	351.8	181.42
Long-Term Debt	126.26	80.52	-	-	-	-
Long-Term Leases	5.46	7.02	11.14	8.44	-	-
Long-Term Unearned Revenue	151.91	149.03	127.25	104.11	65.1	53.72
Long-Term Deferred Tax Liabilities	-	-	-	-	11.31	1.83
Total Liabilities	1,185	1,187	873.1	484.69	428.22	236.97

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Common Stock	160	160	160	160	160	160
Additional Paid-In Capital	1,333	1,314	1,299	1,294	1,294	1,294
Retained Earnings	808.78	797.22	756.04	735.7	546.36	480.83
Treasury Stock	-201.83	-201.83	-176.5	-98.93	-73.27	-
Total Common Equity	2,100	2,070	2,039	2,091	1,928	1,935
Minority Interest	10.99	10.75	16.1	16.53	12.27	10.53
Shareholders' Equity	2,111	2,080	2,055	2,107	1,940	1,946
Total Liabilities & Equity	3,296	3,268	2,928	2,592	2,368	2,183

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Total Debt	574.78	574.2	366.35	35.46	17.15	-
Net Cash (Debt)	324.57	450.05	376.83	790.52	1,346	1,478
Net Cash Growth	46.59%	19.43%	-52.33%	-41.25%	-8.94%	237.97%
Net Cash Per Share	2.13	2.94	2.42	5.01	8.47	9.88
Filing Date Shares Outstanding	146.79	156.07	154.19	157.11	157.73	160
Total Common Shares Outstanding	146.79	156.07	155.1	157.11	157.73	160
Working Capital	544.82	535.46	407	822.21	1,317	1,535
Book Value Per Share	14.31	13.26	13.14	13.31	12.22	12.09
Tangible Book Value	1,880	1,855	1,822	1,883	1,723	1,726
Tangible Book Value Per Share	12.80	11.89	11.75	11.99	10.93	10.79
Buildings	-	924.95	884.79	326.28	96.84	96.84
Machinery	-	202.95	173.84	146.98	61.96	52.32
Construction In Progress	-	408.46	252.27	428.83	314.09	77.09